At the beginning of the 20th century, the few existing clinical studies reported a balanced sex ratio in multiple sclerosis (MS). Some 20 to 30 years later, the first population-based studies in North Wales by Allison and in Switzerland by Ackermann (see references and discussion in Ajdacic-Gross et al.) 1 already noted an overabundance of women. Around that time, the first large wave of the MS epidemic in Western industrialized countries was about to take off. A hundred years later, we are witnessing the second large MS epidemic in Western Europe, and its contours are starting to emerge more clearly. Both epidemics seem to affect women more frequently and are therefore characterized by marked shifts in the sex ratio.
The current epidemic was heralded by a series of epidemiological reports of increasing MS incidence and prevalence rates. 2 In parallel, an increasing female-tomale ratio has been documented for countries in the northern hemisphere. 3 This change is most probably driven by both an increase in relapsing-remitting MS and a decrease in primary progressive MS. 4 There have also been reports from regions with stable incidence rates and sex ratios. 5 In particular, the shift in the sex ratio was not observed in Mediterranean countries nor in some countries of the southern hemisphere. 3 Nevertheless, changes of incidence rates and sex-ratio shifts were also reported by studies from eastern Asia and middle-income countries, thereby painting an increasingly complex picture of the geographic patterns.
Consequently, Koch-Henriksen and Sorensen 6 raised the question in 2011 as to whether the increases in incidence in northern countries were real or simply due to better detection and more rapid diagnosis. Only a few years later, these researchers provided the answer themselves by applying age-period-cohort (APC) analyses to data from the population-based Danish MS Registry. 7 On a factual level, they documented an increase in the incidence rates in women from about 6 (per 100,000) in the 1970s to about 12 after 2000. In men, the corresponding figures were 4 and 6, respectively. Along the same lines, the femaleto-male sex ratio increased from 1.5 to 2. The Danish study observed that these changes started in cohorts born during and after the period of economic prosperity after World War II.
With the APC analysis, the Danish authors produced important insights into the mechanisms of the epidemic and delivered a template for investigating and interpreting the dynamics of MS in other northern countries. They showed that the incidence and sexratio changes were primarily associated with birth cohort effects rather than with (calendar) period effects. In APC analysis, period effects absorb immediate changes such as improvements in ascertainment and diagnosis. This likewise applies for APC analysis of incidence, prevalence, or mortality data. It is noteworthy that period effects in incidence data additionally absorb true risk changes that are related to triggering environmental and behavioral factors. In contrast, birth cohort effects represent true risk changes that are related to susceptibility and emerge long before they manifest themselves in a changing incidence (but are modified by triggering factors). Typically, birth cohort effects exclusively represent environmental and behavioral factors.
APC analysis was also used to uncover the first MS epidemic of the 20th century. This epidemic was determined among birth cohorts born around 1920/1930 in North American, Commonwealth, and Western European countries. 8 Similarly to the recent epidemic, women were more frequently affected than men. A reanalysis focusing on Switzerland showed that the change in the sex ratio was again a matter of birth cohort effects. 1 This analysis also yielded indications that the approximately balanced sex ratios around 1900 were indeed a real phenomenon.
Overall, the pre-World War II and current epidemic share many parallels, the main one being the concurrent change in the sex ratio. 
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It cannot be overlooked that methods are of critical importance in understanding patterns and causes of longitudinal changes in MS. In particular, the time span covered by the data should be long enough and cover at least 20 to 30 years to reliably establish trends. Unfortunately, the observation period is much shorter in most studies, but-very commendably-an increasing number of reports now also include birthcohort-specific data, which provide an additional perspective to incidence and other data types.
However, most studies are still limited in disentangling true changes in risk from data-collection-or diagnosis-driven changes in MS patterns. This is actually the promise of APC analysis: it partitions the data into effects of age (age effects), effects pertaining to current circumstances (period effects), and effects representing predisposition features that underlie the change in risk (birth cohort effects). Even though APC analysis also has some limitations in disentangling birth cohort and period effects, it is better suited than other approaches to tackling long-term change of birth-cohort-related risk. Conveniently, APC analysis can be applied on any continuing database of incidence, prevalence, or mortality data for assessing birth cohort effects.
After excluding that the changes in MS incidence and the female-to-male sex ratio are data artifacts, the real problems in the search for causes begin. In order to fit the observed data, hypothesized causal mechanisms have to meet several criteria concomitantly: explaining the overall incidence change, the concurrent change in the sex ratio, as well as compatibility with risk factor findings and biological models.
First of all, the postulation of birth-cohort-specific changes in MS risk and sex ratio implies that the relapsing-remitting MS has to be a disease with two or more subtypes. Second, the fact that the sex ratio moved up and down in the past suggests that the overabundance of MS in women is not a universal issue. If true, then overly direct biological explanations for sexual dimorphism (hormones, classical genetic approaches) may actually deserve less credit than more complex hypotheses for the cause of MS with multiple levels of risk transformation.
Finally, a series of known risk factors has been discussed in the literature as potential levers of the incidence change: smoking prevalence, sunlight exposure and vitamin D, dietary habits and obesity, and Epstein-Barr virus infection. 2 These factors were examined also as drivers of the change in the sex ratio. The reciprocal approach was also used: factors associated with the sex ratio (e.g. reproductive factors) were examined to determine how they match with the incidence change. 9 However, none of these risk factors was consistent with the observed birth cohort effects in MS.
Interestingly, analogies in birth cohort patterns exist in one other autoimmune disease: Crohn's disease. Its birth cohort shape is similar to that of MS and resembles the first epidemics in the 20th century. 10 If this parallelism indeed shares common causes, it would point to the microbiota as the major potential source of changing MS susceptibility and then also the changing sex ratio.
A last remark is in order: the mutual change of the sex ratio and incidence rates in longitudinal data has a well-known analogy in the age dependency of MS risk. MS around 1900 and MS in children share the characteristics of a balanced sex ratio. Indeed, the sex-ratio differences between males and females only emerge after the onset of puberty, that is, at the same time as MS incidence starts to increase. At first glance, this seems to confirm a universal sex-induced phenomenon. However, results from APC analyses also indicated that these age-sex effects in MS were not constant across birth cohorts and therefore cannot be a universal issue either.
To conclude, existing data suggest that the change in incidence rates of (relapsing-remitting) MS can be accompanied by a change in the sex ratio in the sense of increasing female-to-male ratios. In contrast, a change in the sex ratio must always occur with a change in the incidence rates.
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Changes in the sex ratio are a good indicator of changes in MS incidence -No Melinda Magyari and Nils Koch-Henriksen
With some exceptions, incidence studies from the Western world have shown an increased female-tomale ratio of multiple sclerosis (MS) along with increasing incidence during recent decades. 1,2 The increasing sex ratio has, in reviews, been shown to correlate positively with incidence. In Denmark, 3 the incidence of MS has increased steadily over five decades, and it was strongly correlated with increase in sex ratio because the female incidence increased much more than the male incidence.
So, it is true to say that, in general, change in sex ratio is a good estimator of change in MS incidence. However, in Western Norway, the incidence increased significantly, but the sex ratio increased little and without statistical significance. 4 But only evaluating the sex ratio does not simplify computations. Sex ratio requires calculation of the sex-specific incidences for both sexes. Even the crude incidence without stratification for sex is more informative than the sex ratio alone. Sex ratio is not enough, as phenotypes and epidemiology of MS differ between men and women. The sex ratio in primary progressive MS (PPMS) is lower than in relapsing-remitting MS (RRMS), and a recent Swedish registry study found that the diagnosis of PPMS has significantly decreased. 5 Female incidence has increased in many places, whereas male incidence has been more stable. The speed of increasing incidence is an expression of environmental factors mostly deriving from changes in lifestyle. Environmental exposures that affect both genders could result in increasing incidence. However, there are factors only affecting women and other factors where women may be more susceptible to than men, for example, vitamin D3 has stronger immunomodulatory effects in female than in male MS patients and healthy subjects, 6 and girls are more sensitive than boys to obesity in childhood as a risk factor for MS later in life. 7 Lifestyle-dependent exposures like tobacco smoking may differ between men and women, and the diverging patterns in male and female smoking rates during the last half century may partly explain the increasing gender difference of incidence. Sex ratio is also linked to birth cohorts. 3, 8 One particular risk modulator is only present in women: childbirths, and there is some evidence that it has a certain protective effect against onset of MS. 9 The change in sex ratio with time varies substantially across the world, probably due to differences over time in sex-specific behaviours. Therefore, the
